Skip to content

Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases

Research output: Contribution to journalArticle

  • Alen Krajnc
  • Jürgen Brem
  • Philip Hinchliffe
  • Karina A Calvopina
  • Tharindi D Panduwawala
  • Pauline Lang
  • Jos J.A.G. Kamps
  • Jonathan M Tyrrell
  • Emma Widlake
  • Benjamin G Saward
  • Timothy R Walsh
  • James Spencer
  • Christopher J Schofield
Original languageEnglish
Pages (from-to)8544-8556
Number of pages13
JournalJournal of Medicinal Chemistry
Volume62
Issue number18
DOIs
DateAccepted/In press - 27 Aug 2019
DatePublished (current) - 27 Aug 2019

Abstract

The bicyclic boronate VNRX-5133 (taniborbactam) is a new type of β-lactamase inhibitor in clinical development. We report that VNRX-5133 inhibits serine-β-lactamases (SBLs) and some clinically important metallo-β-lactamases (MBLs), including NDM-1 and VIM-1/2. VNRX-5133 activity against IMP-1 and tested B2/B3 MBLs was lower/not observed. Crystallography reveals how VNRX-5133 binds to the class D SBL OXA-10 and MBL NDM-1. The crystallographic results highlight the ability of bicyclic boronates to inhibit SBLs and MBLs via binding of a tetrahedral (sp3) boron species. The structures imply conserved binding of the bicyclic core with SBLs/MBLs. With NDM-1, by crystallography, we observed an unanticipated VNRX-5133 binding mode involving cyclization of its acylamino oxygen onto the boron of the bicyclic core. Different side-chain binding modes for bicyclic boronates for SBLs and MBLs imply scope for side-chain optimization. The results further support the “high-energy-intermediate” analogue approach for broad-spectrum β-lactamase inhibitor development and highlight the ability of boron inhibitors to interchange between different hybridization states/binding modes.

    Research areas

  • Synthetic biology

    Structured keywords

  • BrisSynBio
  • Bristol BioDesign Institute

Download statistics

No data available

Documents

Documents

  • Full-text PDF (final published version)

    Rights statement: This is the final published version of the article (version of record). It first appeared online via American Chemical Society at https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00911 . Please refer to any applicable terms of use of the publisher.

    Final published version, 3.78 MB, PDF document

    Licence: CC BY

DOI

View research connections

Related faculties, schools or groups